Restore Medical Appoints Chris Cleary as Chairman of the Board

December 1, 2025—Restore Medical Ltd., an Israel-based developer of a transcatheter therapy for heart failure, announced the appointment of Chris Cleary as Chairman of its Board of Directors. Cleary is a former Senior Vice President of Corporate Development at Medtronic.

Restore Medical stated it is advancing a minimally invasive therapy designed to treat patients experiencing heart failure with reduced ejection fraction. The company advised that after encouraging early clinical results for the technology, it is now preparing for the next phase of its clinical development by strengthening its leadership team to support global expansion and an upcoming study in the United States.

According to the company, Cleary brings more than three decades of leadership experience in global health care and medical technology, including corporate strategy, landmark mergers & acquisition, and scaling innovative companies. At Medtronic, Cleary led numerous transformative transactions, including the company’s $50 billion acquisition of Covidien, and several high-impact deals in structural heart, neuromodulation, and spine.

“I’m excited to join Restore at such a pivotal stage,” commented Cleary in Restore Medical’s press release. “The company is addressing a significant unmet need in heart failure with an innovative technology that has the potential to redefine and materially improve patient outcomes. I look forward to supporting the entire Restore team as they continue to build a strong clinical and commercial foundation.”

Gilad Marom, Chief Executive Officer of Restore Medical, added, “Chris has been a driving force behind some of the most important strategic partnerships in MedTech. His depth of experience, strategic perspective, and commitment to advancing meaningful medical innovation will be invaluable as Restore Medical prepares to expand its clinical program and advance toward pivotal studies for its novel transcatheter therapy for heart failure. We are thrilled to welcome him to our board.”